RxDoctor Payments Data

Emma Scott

Hematology · Portland, ORNPI 1821204934

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,576 of the $2,576 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, GSK.

$2,576in general payments, 2019–2025

Across 4 payments — averaging $644.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$3K
$2,110,744in research payments, 2019–2025

Across 72 payments — averaging $29,316 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$1.8M
  • Janssen Research & Development, LLC$114K
  • Takeda Pharmaceuticals U.S.A., Inc.$71K
  • Incyte Corporation$46K
  • E.r. Squibb & Sons, L.L.C.$27K
  • Stemline Therapeutics Inc.$8K

What the payments were for

  • Travel & lodging$2,576100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK4$2,576

How this compares

$2,576 in reported general payments places this provider in the 55th percentile of 27 hematology providers in Oregon.

See all hematology providers in Oregon

Other hematology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →